Boone Capital Management
Boone Capital Management reported 16 stocks worth $428M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TFX (11.5%), MIRM (11.4%) and CI (10.3%). Compared with Q1 2026, the fund opened new positions in VSTS, PNTG and GLUE, added to TFX, CI and IONS, trimmed MIRM and sold out of MDT, AZN and TENX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  TFX Teleflex Incorporated | $49.1M | 11.5% | 387K | +109K (+39%) | 2 of 8 | |
| 2 |  MIRM Mirum Pharmaceuticals Inc | $48.7M | 11.4% | 416K | −5,595 (−1%) | 8 of 8 | |
| 3 |  CI The Cigna Group | $43.9M | 10.3% | 159K | +22K (+16%) | 8 of 8 | |
| 4 |  IONS Ionis Pharmaceuticals Inc | $41.2M | 9.6% | 520K | +19K (+4%) | 4 of 8 | |
| 5 |  UNH Unitedhealth Group Inc | $36.9M | 8.6% | 89K | +9,461 (+12%) | 5 of 8 | |
| 6 |  BMRN Biomarin Pharmaceutical Inc | $33.4M | 7.8% | 583K | +35K (+6%) | 6 of 8 | |
| 7 |  GRDN Guardian Pharmacy | $29.8M | 7.0% | 712K | +81K (+13%) | 2 of 8 | |
| 8 |  VSTS Vestis Corporation | $27.6M | 6.5% | 1.9M | New position | 1 of 8 | |
| 9 |  BBIO Bridgebio Pharma Inc | $25.3M | 5.9% | 340K | +111K (+48%) | 4 of 8 | |
| 10 |  PNTG Pennant Group Inc | $19.1M | 4.5% | 516K | New position | 5 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Boone Capital Management 13F FAQ
What does Boone Capital Management own?
Boone Capital Management reported 16 stocks worth $428M in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are TFX (11.5%), MIRM (11.4%) and CI (10.3%). The table above lists every position in the filing (the top 10 without an account).
What did Boone Capital Management buy and sell in Q2 2026?
Compared with Q1 2026: 7 new positions, 8 added to, 1 trimmed and 4 sold out. New positions include VSTS, PNTG and GLUE. It sold all of MDT, AZN and TENX.
When will Boone Capital Management file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Boone Capital Management's portfolio worth?
The Q2 2026 filing reports $428M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.